NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities. Additional information: The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Nor...
Buyer
COMMERCIAL MEDICINES UNIT
Value
£41,000,000
Published
17 Aug 2018
Closes
23 Mar 2016
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
31 Aug 2016
Contract ends
31 Aug 2017
CPV classifications
33141000
Disposable non-chemical medical consumables and haematological consumables
Lots
Lot default NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
£50,600,000
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities. Additi...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
17 Aug 2018
Awarded contract notice on Contracts Finder
Award notice · Web page
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Not provided
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Application/x zip compressed · ZIP archive
Ojeu contract notice amendment due to value to take account of 48 months
Not provided
Ojeu contract notice amendment due to value to take account of 48 months
Application/pdf · PDF
Award documentation
Not provided
Award documentation
Application/x zip compressed · ZIP archive
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Not provided
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Application/x zip compressed · ZIP archive
Ojeu contract notice amendment due to value to take account of 48 months
Not provided
Ojeu contract notice amendment due to value to take account of 48 months
Application/pdf · PDF
Award documentation
Not provided
Award documentation
Application/x zip compressed · ZIP archive
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Not provided
Invitation to Offer documents - NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Application/x zip compressed · ZIP archive
Ojeu contract notice amendment due to value to take account of 48 months
Not provided
Ojeu contract notice amendment due to value to take account of 48 months
Application/pdf · PDF
Award documentation
Not provided
Award documentation
Application/x zip compressed · ZIP archive
Contains public sector information licensed under the Open Government Licence v3.0.